个人简介：       

Dr. Karen Bernstein is Co-Founder and Chairman of BioCentury Inc. and was Editor-in-Chief from October 1992 to August 2015. She holds a Ph.D. in political science from Stanford University and a B.A. in politics and history from Brandeis University, where she served for many years as a member of the Brandeis University Science Advisory Council. 

In 2005, the annual gathering of biotechnology chief executive officers at The Biotech Meeting in Laguna Niguel, Calif., inducted Karen into their Hall of Fame, citing her lifetime contribution to the biotech community. 

In 2007, Karen received a Special Recognition award at the American Liver Foundation's Salute to Excellence, honoring individuals who have made an outstanding contribution to biotechnology and medical innovation. 

In 2013, she was named as one of the 100 Women of Influence in Silicon Valley by the Silicon Valley Business Journal. 

In 2015, Scientific American named Karen as one of The WorldVIEW 100 most influential people in biotech today. 

In 2016, she was named Commentator of the Year by the European Mediscience Awards.She is on the Board of Trustees of the Keck Graduate Institute of the Applied Life Sciences and is a member of the board of advisors of KGI's School of Pharmacy. 

She is a director at Ovid Therapeutics Inc., which is focused on developing drugs for orphan diseases of the brain, and at Achaogen Inc., which is developing drugs to treat multi-drug resistant gram-negative infections.

公司简介： 

Since 1993, BioCentury, Inc. has been internationally recognized as the leading provider of value-added information, analysis and data for biotechnology and pharmaceutical companies, investors, academia and government on the strategic issues essential to the formation, development and sustainability of life science ventures.

BioCentury employs a fully integrated multimedia platform — including publications, video, online data solutions, conferences, and eLearning programs — to provide its audience with authoritative and up-to-date intelligence about corporate strategy, partnering, emerging technology, clinical data, public policy and the financial markets. 

The company publishes the weekly editions of its flagship publication, BioCentury®, and BioCentury Week in Review, plus daily editions of BioCentury Extra. BioCentury also publishes BioCentury Innovations a weekly translational science journal. 

The company also markets BCIQ, the industry's premiere business intelligence and research database. It provides easy access to data on thousands of companies and products and $400+ billion in financings.

公司官网：www.biocentury.com